Featuring the latest ductal carcinoma in situ (DCIS) news and updates from DCIS Understood, including program developments, research information, patient stories, advocacy opportunities, and organizational news.

  • LORD (LOw-Risk DCIS) Clinical Trial

    At the recent 15th European Breast Cancer Conference (EBCC15), researchers shared encouraging early findings from the LORD (LOw Risk DCIS) clinical trial , a major international study exploring whether some people diagnosed with low-risk ductal carcinoma in situ (DCIS) can safely avoid immediate surgery.

  • Navigating DCIS Outside the Traditional Path

    A newly published study in Sociology of Health & Illness explores how some women diagnosed with ductal carcinoma in situ (DCIS) are navigating their diagnosis outside the traditional treatment pathway. Rather than following standard-of-care approaches such as surgery or radiation, these women are turning to an online community to help make sense of their diagnosis, weigh treatment decisions, and find support. The study offers a window into how patients understand risk, interact with the medical system, and navigate uncertainty in the absence of clear answers.

  • There is growing concern about the overtreatment of ductal carcinoma in situ (DCIS), meaning many individuals receive treatments that may not improve long-term outcomes. Overtreatment refers to treating a disease or condition even though it may not have caused symptoms or affected a patient’s lifespan. While DCIS can progress to invasive breast cancer, studies suggest that a substantial proportion of cases may remain harmless if left untreated, and that standard treatments carry physical and emotional side effects. This post explores why overtreatment is a concern and what emerging evidence shows.

  • DCIS Understood - Rise Up Presentation

    Last month, DCIS Understood had the honor of attending—and presenting at—the RISE UP (Revolutionizing Investigations to StEp Up Prevention) for Breast Cancer and Women’s Health conference hosted by UCSF. RISE UP is not a typical breast cancer conference. Its focus extends beyond treatment into prevention, early intervention, equity, innovation, and women’s health more broadly. The unifying message throughout the program was clear: we must think earlier, think differently, and think more holistically about breast cancer care. That framing could not be more relevant to DCIS.

Subscribe

Subscribe below for the latest DCIS news and updates

* indicates required

Connect

Categories

Donate Today

Help ensure that every woman diagnosed with DCIS has access to trustworthy, evidence-based education and compassionate guidance. Your donation advances equitable, patient-centered resources for individuals and families nationwide.